July 24, 2017July 24, 2017
Regulatory T-cell Levels Could Be Used to Diagnose Juvenile Arthritis, Study Reports

Patients with juvenile idiopathic arthritis have a lot of regulatory T-cells in their blood, particularly during active stages of ... Read more
July 20, 2017July 20, 2017
EU Commission Approves Biosimilar Erelzi to Treat Juvenile Arthritis, Other Chronic Inflammatory Diseases

The European Commission has approved the use of Erelzi – a biosimilar to Enbrel (etanercept) – to treat juvenile ... Read more
July 19, 2017July 19, 2017
Imraldi, Candidate for Humira Biosimilar, Is Step Closer to Approval in Europe

Samsung Bioepis received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ... Read more
July 17, 2017July 17, 2017
Arthritis National Research Foundation Earns Perfect Score from Charity Navigator

The Arthritis National Research Foundation (ANRF) has earned a perfect classification from the online Charity Navigator, with a score ... Read more
July 13, 2017July 13, 2017
Rheumatologists, Surgeons Team Up on Guidelines to Prevent Joint Replacement Infections

Top American rheumatologists and orthopedic surgeons have collaborated for the first time to on guidelines aimed at reducing the risk ... Read more
July 11, 2017July 11, 2017
BMS Releases New Prefilled Injections of Orencia for Juvenile Idiopathic Arthritis Patients

Bristol-Myers Squibb recently announced that a new U.S. Food and Drug Administration (FDA)-approved formulation of Orencia (abatacept) is now available ... Read more

Regulatory T-cell Levels Could Be Used to Diagnose Juvenile Arthritis, Study Reports

Patients with juvenile idiopathic arthritis have a lot of regulatory T-cells in their blood, particularly during active stages of the disease, a study indicates. The findings could lead to ... Read more

July 20, 2017July 20, 2017

EU Commission Approves Biosimilar Erelzi to Treat Juvenile Arthritis, Other Chronic Inflammatory Diseases

The European Commission has approved the use of Erelzi – a biosimilar to Enbrel (etanercept) – to treat juvenile arthritis and several other chronic inflammatory diseases. Erelzi is produced ... Read more

July 19, 2017July 19, 2017

Imraldi, Candidate for Humira Biosimilar, Is Step Closer to Approval in Europe

Samsung Bioepis received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) on its marketing application for Imraldi, a Humira ... Read more

July 17, 2017July 17, 2017

Arthritis National Research Foundation Earns Perfect Score from Charity Navigator

The Arthritis National Research Foundation (ANRF) has earned a perfect classification from the online Charity Navigator, with a score of 100 percent for fiscal management and accountability. This is ... Read more

July 13, 2017July 13, 2017

Rheumatologists, Surgeons Team Up on Guidelines to Prevent Joint Replacement Infections

Top American rheumatologists and orthopedic surgeons have collaborated for the first time to on guidelines aimed at reducing the risk of joint infection when a juvenile arthritis patient has to ... Read more

July 11, 2017July 11, 2017

BMS Releases New Prefilled Injections of Orencia for Juvenile Idiopathic Arthritis Patients

Bristol-Myers Squibb recently announced that a new U.S. Food and Drug Administration (FDA)-approved formulation of Orencia (abatacept) is now available for patients with moderate to severely active polyarticular juvenile idiopathic ... Read more